The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Ovulation Induction

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Ovulation Induction


Psychiatry related information on Ovulation Induction


High impact information on Ovulation Induction


Chemical compound and disease context of Ovulation Induction


Biological context of Ovulation Induction


Anatomical context of Ovulation Induction


Associations of Ovulation Induction with chemical compounds

  • Twenty-nine patients underwent 33 ovarian stimulation cycles with either tamoxifen 60 mg/d alone (Tam-IVF) or in combination with low-dose follicle-stimulating hormone (TamFSH-IVF) or letrozole 5 mg in combination with FSH (Letrozole-IVF) [26].
  • Multiple follicular development during ovarian stimulation associated with increased plasma E2 concentration (mean peak plasma E2 level, 2430 +/- 428 pg/mL, range 1630-3840 pg/mL) were observed in each woman [27].
  • To investigate the degree to which endogenous increases in estradiol (E2) and progesterone (P4) are associated with changes in the renin system, we studied eight patients undergoing ovarian stimulation for in vitro fertilization (FSH/human menopausal gonadotropin or clomiphene citrate for 5-11 days, followed by hCG) [28].
  • Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy [28].
  • Ovarian suppression was carried out with leuprolide acetate (1 mg, sc) daily until the serum estradiol level was 30 pg/mL and was continued thereafter during ovarian stimulation with im human menopausal gonadotropin or FSH [29].

Gene context of Ovulation Induction


Analytical, diagnostic and therapeutic context of Ovulation Induction


  1. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. Jordan, V.C., Fritz, N.F., Langan-Fahey, S., Thompson, M., Tormey, D.C. J. Natl. Cancer Inst. (1991) [Pubmed]
  2. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Venn, A., Watson, L., Lumley, J., Giles, G., King, C., Healy, D. Lancet (1995) [Pubmed]
  3. Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptor-deficient mice. Hentges, S.T., Low, M.J. Endocrinology (2002) [Pubmed]
  4. Gonadotropin-releasing hormone and TGF-beta activate MAP kinase and differentially regulate fibronectin expression in endometrial epithelial and stromal cells. Luo, X., Ding, L., Chegini, N. Am. J. Physiol. Endocrinol. Metab. (2004) [Pubmed]
  5. Relationship between leptin and oestrogens in healthy women. Mannucci, E., Ognibene, A., Becorpi, A., Cremasco, F., Pellegrini, S., Ottanelli, S., Rizzello, S.M., Massi, G., Messeri, G., Rotella, C.M. Eur. J. Endocrinol. (1998) [Pubmed]
  6. Grief, depression, and coping in women undergoing infertility treatment. Lukse, M.P., Vacc, N.A. Obstetrics and gynecology. (1999) [Pubmed]
  7. Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues. Barbieri, R.L., Hornstein, M.D. Endocr. Rev. (1999) [Pubmed]
  8. Plasma prorenin response to human chorionic gonadotropin in ovarian-hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations. Itskovitz, J., Sealey, J.E., Glorioso, N., Rosenwaks, Z. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  9. Allosteric Activation of the Follicle-stimulating Hormone (FSH) Receptor by Selective, Nonpeptide Agonists. Yanofsky, S.D., Shen, E.S., Holden, F., Whitehorn, E., Aguilar, B., Tate, E., Holmes, C.P., Scheuerman, R., Maclean, D., Wu, M.M., Frail, D.E., López, F.J., Winneker, R., Arey, B.J., Barrett, R.W. J. Biol. Chem. (2006) [Pubmed]
  10. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. Beckers, N.G., Macklon, N.S., Eijkemans, M.J., Ludwig, M., Felberbaum, R.E., Diedrich, K., Bustion, S., Loumaye, E., Fauser, B.C. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  11. The effectiveness of IVF in unexplained infertility: a systematic Cochrane review. 2002,. Pandian, Z., Bhattacharya, S., Nikolaou, D., Vale, L., Templeton, A. Hum. Reprod. (2003) [Pubmed]
  12. Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment. Egbase, P.E., Al Sharhan, M., Berlingieri, P., Grudzinskas, J.G. Hum. Reprod. (2000) [Pubmed]
  13. Improved pregnancy outcome with the addition of leuprolide acetate to gonadotropins for in vitro fertilization. Chetkowski, R.J., Kruse, L.R., Nass, T.E. Fertil. Steril. (1989) [Pubmed]
  14. A double-blind, randomized, placebo-controlled study to assess the efficacy of ketoconazole for reducing the risk of ovarian hyperstimulation syndrome. Parsanezhad, M.E., Alborzi, S., Pakniat, M., Schmidt, E.H. Fertil. Steril. (2003) [Pubmed]
  15. Successful transfer of frozen-thawed embryos obtained after subtotal colectomy for colorectal cancer and before fluorouracil-based chemotherapy. Azem, F., Amit, A., Merimsky, O., Lessing, J.B. Gynecol. Oncol. (2004) [Pubmed]
  16. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Fauser, B.C., Devroey, P. Trends Endocrinol. Metab. (2003) [Pubmed]
  17. In vitro fertilisation. A review of drug therapy and clinical management. Jennings, J.C., Moreland, K., Peterson, C.M. Drugs (1996) [Pubmed]
  18. Human controlled ovarian hyperstimulation outcome is a polygenic trait. de Castro, F., Morón, F.J., Montoro, L., Galán, J.J., Hernández, D.P., Padilla, E.S., Ramírez-Lorca, R., Real, L.M., Ruiz, A. Pharmacogenetics (2004) [Pubmed]
  19. Intrauterine insemination after ovarian stimulation with clomiphene citrate: predictive potential of inseminating motile count and sperm morphology. Ombelet, W., Vandeput, H., Van de Putte, G., Cox, A., Janssen, M., Jacobs, P., Bosmans, E., Steeno, O., Kruger, T. Hum. Reprod. (1997) [Pubmed]
  20. Pregnancy outcome of in vitro fertilization/intracytoplasmic sperm injection with profound teratospermia. McKenzie, L.J., Kovanci, E., Amato, P., Cisneros, P., Lamb, D., Carson, S.A. Fertil. Steril. (2004) [Pubmed]
  21. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. Hohmann, F.P., Macklon, N.S., Fauser, B.C. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  22. Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome. Hughes, E.G., Robertson, D.M., Handelsman, D.J., Hayward, S., Healy, D.L., de Kretser, D.M. J. Clin. Endocrinol. Metab. (1990) [Pubmed]
  23. Use of a gonadotropin-releasing hormone agonist during ovarian stimulation leads to significant concentrations of peptide in follicular fluids. Loumaye, E., Coen, G., Pampfer, S., Vankrieken, L., Thomas, K. Fertil. Steril. (1989) [Pubmed]
  24. Modulation of endometrial transformation in gonadotrophin-stimulated and unstimulated pseudo-pregnant rabbits: studies with the progesterone receptor antagonist, onapristone. Krusche, C.A., Herrler, A., Classen-Linke, I., Hegele-Hartung, C., von Rango, U., Beier, H.M. Mol. Hum. Reprod. (2000) [Pubmed]
  25. Concurrent IVF and spontaneous conception resulting in a quadruplet pregnancy. Milki, A.A., Hinckley, M.D., Grumet, F.C., Chitkara, U. Hum. Reprod. (2001) [Pubmed]
  26. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. Oktay, K., Buyuk, E., Libertella, N., Akar, M., Rosenwaks, Z. J. Clin. Oncol. (2005) [Pubmed]
  27. Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. Manau, D., Balasch, J., Arroyo, V., Jiménez, W., Fábregues, F., Casamitjana, R., Creus, M., Vanrell, J.A. J. Clin. Endocrinol. Metab. (1998) [Pubmed]
  28. Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. Sealey, J.E., Itskovitz-Eldor, J., Rubattu, S., James, G.D., August, P., Thaler, I., Levron, J., Laragh, J.H. J. Clin. Endocrinol. Metab. (1994) [Pubmed]
  29. The ovarian contribution to peripherally derived serum C19 conjugates. Matteri, R.K., Stanczyk, F.Z., Cassidenti, D.L., Paulson, R.J., Lobo, R.A. J. Clin. Endocrinol. Metab. (1992) [Pubmed]
  30. Follicular fluid insulin-like growth factor-I and insulin-like growth factor-binding protein-1 and -3 vary as a function of ovarian reserve and ovarian stimulation. Stadtmauer, L., Vidali, A., Lindheim, S.R., Sauer, M.V. J. Assist. Reprod. Genet. (1998) [Pubmed]
  31. The pathophysiology of endometriosis-associated infertility: follicular environment and embryo quality. Pellicer, A., Albert, C., Garrido, N., Navarro, J., Remohí, J., Simón, C. J. Reprod. Fertil. Suppl. (2000) [Pubmed]
  32. A therapeutic role of prolactin supplementation in ovarian stimulation for in vitro fertilization: the bromocriptine-rebound method. Jinno, M., Katsumata, Y., Hoshiai, T., Nakamura, Y., Matsumoto, K., Yoshimura, Y. J. Clin. Endocrinol. Metab. (1997) [Pubmed]
  33. Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols. Neulen, J., Wenzel, D., Hornig, C., Wünsch, E., Weissenborn, U., Grunwald, K., Büttner, R., Weich, H. Hum. Reprod. (2001) [Pubmed]
  34. Follicular fluid markers of oocyte developmental potential. Mendoza, C., Ruiz-Requena, E., Ortega, E., Cremades, N., Martinez, F., Bernabeu, R., Greco, E., Tesarik, J. Hum. Reprod. (2002) [Pubmed]
  35. Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents? Griesinger, G., Felberbaum, R.E., Schultze-Mosgau, A., Diedrich, K. Drugs (2004) [Pubmed]
  36. A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI. Wikland, M., Bergh, C., Borg, K., Hillensjö, T., Howles, C.M., Knutsson, A., Nilsson, L., Wood, M. Hum. Reprod. (2001) [Pubmed]
  37. Colour Doppler analysis of peri-implantation utero-ovarian haemodynamics in women with excessively high oestradiol concentrations after ovarian stimulation. Basir, G.S., Lam, T.P., Chau, M.T., Ng, E.H., O, W.S., Ho, P.C. Hum. Reprod. (2001) [Pubmed]
  38. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. Mitwally, M.F., Casper, R.F. J. Soc. Gynecol. Investig. (2004) [Pubmed]
  39. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Humaidan, P., Bungum, L., Bungum, M., Andersen, C.Y. Hum. Reprod. (2002) [Pubmed]
WikiGenes - Universities